Back to News
Top StoriesMarketWatch1d ago
Moderna’s cancer vaccine hits its targets, but a data leak rattles investors and the stock tumbles
A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.
Read Full Article on MarketWatchMENTIONED STOCKS
More Top Stories News
Walmart, Best Buy and other stores now use digital price tags. Critics say they could lead to different prices for different shoppers.
MarketWatch·5h ago
Even the wealthy increasingly want all-inclusive resorts
MarketWatch·2h ago
The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
MarketWatch·3h ago
Think annuities are a rip-off? Now might be the perfect time to reconsider.
MarketWatch·3h ago
Oil markets are on edge ahead of the weekend, as midterm elections near and fresh U.S. strikes on Iran are predicted
MarketWatch·3h ago
Content sourced from MarketWatch. Not financial advice.